Role of IL-6 and IGF-1 in sarcopenia

Nur Riviati(1), Legiran Legiran(2*), Taufik Indrajaya(3), Irsan Saleh(4)
(1) Universitas Sriwijaya
(2) Universitas Sriwijaya
(3) 
(4) Universitas Sriwijaya
(*) Corresponding Author
DOI : 10.30604/jika.v8i1.1625

Abstract

Background: Sarcopenia is a syndrome characterized by decreased muscle mass and decreased muscle strength and muscle function. Oxidative stress and inflammatory processes are known to contribute to sarcopenia by releasing the catabolic stimuli interleukin-6 (IL-6) and insulin-like growth factor (IGF). Methods: The method used is a literature review by collecting appropriate articles from the PubMed and Google Scholar databases. Results: Low IL-6 can trigger satellite cell activity and myotube regeneration, whereas if IL-6 production increases chronically, it triggers muscle wasting. Changes in muscle size are the result of changes in the synthesis and degradation of muscle protein. IGF-1, where signal changes are strongly related to muscle size. IGF-1 binding to the receptor causes intracellular phosphorylation of the adapter protein Shc or insulin receptor substrate (IRS-1). Conclusion: The role of IGF-1 and IL-6 can be helpful as diagnostic and prognostic parameters for sarcopenia.

 

Abstrak: Latar belakang: Sarkopenia adalah sindrom yang ditandai dengan penurunan massa otot disertai penurunan kekuatan otot dan atau fungsi otot. Stres oksidatif dan proses inflamasi dikenal sebagai faktor pemicu untuk sarkopenia dengan melepaskan rangsangan katabolik interleukin-6 (IL-6) dan IGF1. Metode: Metode yang digunakan adalah literature review dengan mengumpulkan artikel-artikel yang sesuai dari data base PubMed dan google sholar. Hasil: IL-6 yang rendah dapat mencetuskan aktivitas sel-sel satelit dan regenerasi myotube, sedangkan bila produksi IL-6 meningkat secara kronik mencetuskan muscle wasting. Perubahan ukuran otot merupakan dampak dari perubahan sintesis dan degradasi protein otot. IGF-1 dimana perubahan sinyal berhubungan kuat dengan ukuran otot. Ikatan IGF-1 pada reseptor menyebabkan fosforilasi intracellular adaptor proteins Shc atau insulin receptor substrate (IRS-1). Kesimpulan: Peran IGF-1 dan IL-6 dapat berguna sebagai parameter diagnostik dan prognostic terhadap kejadian sarcopenia.

Keywords


IL-6; IGF-1; sarcopenia

References


Ahmad, S. S., Ahmad, K., Lee, E. J., Lee, Y. H., & Choi, I. (2020). Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases. Cells, 9(8). https://doi.org/10.3390/CELLS9081773

Ascenzi, F., Barberi, L., Dobrowolny, G., Villa Nova Bacurau, A., Nicoletti, C., Rizzuto, E., Rosenthal, N., Scicchitano, B. M., & Musarò, A. (2019). Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell, 18(3). https://doi.org/10.1111/ACEL.12954

Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, G., & Veronese, N. (2017). Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas, 96, 10–15. https://doi.org/10.1016/J.MATURITAS.2016.11.006

Barbiera, A., Pelosi, L., Sica, G., & Scicchitano, B. M. (2020). Nutrition and microRNAs: Novel Insights to Fight Sarcopenia. Antioxidants (Basel, Switzerland), 9(10), 1–23. https://doi.org/10.3390/ANTIOX9100951

Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J. Y., & Bruyère, O. (2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PloS One, 12(1). https://doi.org/10.1371/JOURNAL.PONE.0169548

Belizário, J. E., Fontes-Oliveira, C. C., Borges, J. P., Kashiabara, J. A., & Vannier, E. (2016). Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6. SpringerPlus, 5(1). https://doi.org/10.1186/S40064-016-2197-2

Bonato, M., Turrini, F., Galli, L., Banfi, G., & Cinque, P. (2020). The Role of Physical Activity for the Management of Sarcopenia in People Living with HIV. International Journal of Environmental Research and Public Health, 17(4). https://doi.org/10.3390/IJERPH17041283

Erfin, M., Riviati, N., Kurniati, N., Bahar, E., Sukandi, E., & Sudarto. (2021). Correlation of Serum IL-6 Levels with Muscle Mass, Muscle Strength, and Physical Performance in Elderly Gymnastics Community in Mohammad Hoesin General Hospital Palembang. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 5(9), 862–870. https://doi.org/10.32539/BSM.V5I9.351

Grosicki, G. J., Barrett, B. B., Englund, D. A., Liu, C., Travison, T. G., Cederholm, T., Koochek, A., von Berens, Gustafsson, T., Benard, T., Reid, K. F., & Fielding, R. A. (2020). Circulating Interleukin-6 Is Associated with Skeletal Muscle Strength, Quality, and Functional Adaptation with Exercise Training in Mobility-Limited Older Adults. The Journal of Frailty & Aging, 9(1), 57–63. https://doi.org/10.14283/JFA.2019.30

Gusti Putu Suka Aryana, I., Wiradewi Lestari, A., Putrawan, I., Ketut Rai Purnami, N., Nyoman Astika, I., Tuty Kuswardhani, R., & Putu Suka Aryana, G. (2018). The The relationship between IL-6 and CRP with Sarcopenia in indigenous elderly population at Pedawa Village, Buleleng, Bali, Indonesia. Health Science Journal of Indonesia, 9(1), 37–44. https://doi.org/10.22435/HSJI.V9I1.467

Keller, K. (2019). Sarcopenia. Wiener Medizinische Wochenschrift (1946), 169(7–8), 157–172. https://doi.org/10.1007/S10354-018-0618-2

Levine, M. E., Suarez, J. A., Brandhorst, S., Balasubramanian, P., Cheng, C. W., Madia, F., Fontana, L., Mirisola, M. G., Guevara-Aguirre, J., Wan, J., Passarino, G., Kennedy, B. K., Wei, M., Cohen, P., Crimmins, E. M., & Longo, V. D. (2014). Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metabolism, 19(3), 407–417. https://doi.org/10.1016/J.CMET.2014.02.006

Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., & Abete, P. (2018). Oxidative stress, aging, and diseases. Clinical Interventions in Aging, 13, 757–772. https://doi.org/10.2147/CIA.S158513

Musarò, A., & Scicchitano, B. M. (2019). Counteracting sarcopenia: the role of IGF-1 isoforms. Aging, 11(11), 3410–3411. https://doi.org/10.18632/AGING.102027

Nelke, C., Dziewas, R., Minnerup, J., Meuth, S. G., & Ruck, T. (2019). Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, 49, 381–388. https://doi.org/10.1016/J.EBIOM.2019.10.034

Petermann-Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., & Celis-Morales, C. (2020). New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Age and Ageing, 49(2), 300–304. https://doi.org/10.1093/AGEING/AFZ126

Pratiwi, Y. S., Lesmana, R., Setiawan, S., & Purba, A. (2019). Tinjauan Pustaka : Autophagy dan Sarkopenia. Syifa’ MEDIKA: Jurnal Kedokteran Dan Kesehatan, 10(1), 30–44. https://doi.org/10.32502/SM.V10I1.1781

Rachim, R., Sudarso, A., Pricillia Makagiansar, S., Bakri, S., Rasyid, H., Aman, A. M., Kasim, H., & Seweng, A. (n.d.). European Journal of Molecular & Clinical Medicine Expression Of Interleukin-6 Levels In Elderly Sarcopenia.

Tuttle, C. S. L., Thang, L. A. N., & Maier, A. B. (2020). Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis. Ageing Research Reviews, 64. https://doi.org/10.1016/J.ARR.2020.101185

Wiedmer, P., Jung, T., Castro, J. P., Pomatto, L. C. D., Sun, P. Y., Davies, K. J. A., & Grune, T. (2021). Sarcopenia - Molecular mechanisms and open questions. Ageing Research Reviews, 65. https://doi.org/10.1016/J.ARR.2020.101200

Yoshida, T., & Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9(9). https://doi.org/10.3390/CELLS9091970


Article Statistic

Abstract view : 218 times
PDF (Bahasa Indonesia) views : 109 times

Dimensions Metrics

How To Cite This :

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.